
Erica S Y Lin
Examiner (ID: 4581, Phone: (571)270-7911 , Office: P/2853 )
| Most Active Art Unit | 2853 |
| Art Unit(s) | 2853, 2861 |
| Total Applications | 1103 |
| Issued Applications | 882 |
| Pending Applications | 99 |
| Abandoned Applications | 155 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17822705
[patent_doc_number] => 11427643
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-30
[patent_title] => Targeted protein degradation
[patent_app_type] => utility
[patent_app_number] => 16/879896
[patent_app_country] => US
[patent_app_date] => 2020-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16959
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16879896
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/879896 | Targeted protein degradation | May 20, 2020 | Issued |
Array
(
[id] => 18412114
[patent_doc_number] => 11666641
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-06
[patent_title] => CRISPR nuclease
[patent_app_type] => utility
[patent_app_number] => 17/594761
[patent_app_country] => US
[patent_app_date] => 2020-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 23807
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17594761
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/594761 | CRISPR nuclease | Apr 29, 2020 | Issued |
Array
(
[id] => 17207751
[patent_doc_number] => 11168110
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-09
[patent_title] => Method for separation of monomeric polypeptides from aggregated polypeptides
[patent_app_type] => utility
[patent_app_number] => 16/851458
[patent_app_country] => US
[patent_app_date] => 2020-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10988
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16851458
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/851458 | Method for separation of monomeric polypeptides from aggregated polypeptides | Apr 16, 2020 | Issued |
Array
(
[id] => 17968259
[patent_doc_number] => 11485773
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-11-01
[patent_title] => Protease inhibitor:protease sensitive expression system and method improving the therapeutic activity and specificity of proteins and phage and phagemids delivered by bacteria
[patent_app_type] => utility
[patent_app_number] => 16/818631
[patent_app_country] => US
[patent_app_date] => 2020-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 30
[patent_no_of_words] => 11950
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16818631
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/818631 | Protease inhibitor:protease sensitive expression system and method improving the therapeutic activity and specificity of proteins and phage and phagemids delivered by bacteria | Mar 12, 2020 | Issued |
Array
(
[id] => 17845118
[patent_doc_number] => 11434474
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-06
[patent_title] => Modulation of lipid metabolism for protein production
[patent_app_type] => utility
[patent_app_number] => 16/818162
[patent_app_country] => US
[patent_app_date] => 2020-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 32
[patent_no_of_words] => 28719
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16818162
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/818162 | Modulation of lipid metabolism for protein production | Mar 12, 2020 | Issued |
Array
(
[id] => 17742831
[patent_doc_number] => 11390888
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-19
[patent_title] => Methods for genomic integration
[patent_app_type] => utility
[patent_app_number] => 16/816172
[patent_app_country] => US
[patent_app_date] => 2020-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 36
[patent_no_of_words] => 38850
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16816172
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/816172 | Methods for genomic integration | Mar 10, 2020 | Issued |
Array
(
[id] => 16500064
[patent_doc_number] => 10865441
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-15
[patent_title] => Mutant Taq polymerase for faster amplification
[patent_app_type] => utility
[patent_app_number] => 16/813425
[patent_app_country] => US
[patent_app_date] => 2020-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8964
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 214
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16813425
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/813425 | Mutant Taq polymerase for faster amplification | Mar 8, 2020 | Issued |
Array
(
[id] => 16204892
[patent_doc_number] => 20200237882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => Compositions and Methods for Treating Pathological Calcification and Ossification
[patent_app_type] => utility
[patent_app_number] => 16/813315
[patent_app_country] => US
[patent_app_date] => 2020-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25825
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16813315
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/813315 | Compositions and methods for treating pathological calcification and ossification | Mar 8, 2020 | Issued |
Array
(
[id] => 16343967
[patent_doc_number] => 20200308617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => METHODS FOR IMPROVED PRODUCTION OF REBAUDIOSIDE D AND REBAUDIOSIDE M
[patent_app_type] => utility
[patent_app_number] => 16/799541
[patent_app_country] => US
[patent_app_date] => 2020-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34017
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16799541
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/799541 | Methods for improved production of Rebaudioside D and Rebaudioside M | Feb 23, 2020 | Issued |
Array
(
[id] => 16009381
[patent_doc_number] => 20200179533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => THYMIDINE KINASE GENE
[patent_app_type] => utility
[patent_app_number] => 16/798198
[patent_app_country] => US
[patent_app_date] => 2020-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38470
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -63
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16798198
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/798198 | Thymidine kinase gene | Feb 20, 2020 | Issued |
Array
(
[id] => 17133150
[patent_doc_number] => 11134681
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-05
[patent_title] => Fusion proteins and methods for stimulating plant growth, protecting plants from pathogens, and immobilizing
[patent_app_type] => utility
[patent_app_number] => 16/785870
[patent_app_country] => US
[patent_app_date] => 2020-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 19107
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16785870
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/785870 | Fusion proteins and methods for stimulating plant growth, protecting plants from pathogens, and immobilizing | Feb 9, 2020 | Issued |
Array
(
[id] => 16238577
[patent_doc_number] => 20200255811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => PHOSPHOTRIESTERASE ENZYME TETHERED MONOMER
[patent_app_type] => utility
[patent_app_number] => 16/783841
[patent_app_country] => US
[patent_app_date] => 2020-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10027
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16783841
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/783841 | PHOSPHOTRIESTERASE ENZYME TETHERED MONOMER | Feb 5, 2020 | Abandoned |
Array
(
[id] => 16525538
[patent_doc_number] => 20200399618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => Compositions and Methods for Pesticide Degradation
[patent_app_type] => utility
[patent_app_number] => 16/778653
[patent_app_country] => US
[patent_app_date] => 2020-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6523
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16778653
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/778653 | Compositions and Methods for Pesticide Degradation | Jan 30, 2020 | Abandoned |
Array
(
[id] => 15931765
[patent_doc_number] => 20200157516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => PEPTIDE-MEDIATED DELIVERY OF RNA-GUIDED ENDONUCLEASE INTO CELLS
[patent_app_type] => utility
[patent_app_number] => 16/752887
[patent_app_country] => US
[patent_app_date] => 2020-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43640
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16752887
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/752887 | PEPTIDE-MEDIATED DELIVERY OF RNA-GUIDED ENDONUCLEASE INTO CELLS | Jan 26, 2020 | Abandoned |
Array
(
[id] => 17664156
[patent_doc_number] => 11357832
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-14
[patent_title] => Treatment of cognitive impairment of hunter syndrome by intrathecal delivery of iduronate-2-sulfatase
[patent_app_type] => utility
[patent_app_number] => 16/744140
[patent_app_country] => US
[patent_app_date] => 2020-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 27696
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16744140
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/744140 | Treatment of cognitive impairment of hunter syndrome by intrathecal delivery of iduronate-2-sulfatase | Jan 14, 2020 | Issued |
Array
(
[id] => 17088626
[patent_doc_number] => 11116796
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-14
[patent_title] => Nanoparticle formulations
[patent_app_type] => utility
[patent_app_number] => 16/742082
[patent_app_country] => US
[patent_app_date] => 2020-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 32
[patent_no_of_words] => 21044
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 299
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16742082
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/742082 | Nanoparticle formulations | Jan 13, 2020 | Issued |
Array
(
[id] => 15899011
[patent_doc_number] => 20200149024
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => Engineered CRISPR-Cas9 Nucleases
[patent_app_type] => utility
[patent_app_number] => 16/734935
[patent_app_country] => US
[patent_app_date] => 2020-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20338
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16734935
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/734935 | Engineered CRISPR-Cas9 nucleases | Jan 5, 2020 | Issued |
Array
(
[id] => 15769435
[patent_doc_number] => 20200115735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-16
[patent_title] => NOVEL LUCIFERASE SEQUENCES UTILIZING INFRARED-EMITTING SUBSTRATES TO PRODUCE ENHANCED LUMINESCENCE
[patent_app_type] => utility
[patent_app_number] => 16/725586
[patent_app_country] => US
[patent_app_date] => 2019-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27864
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16725586
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/725586 | Luciferase sequences utilizing infrared-emitting substrates to produce enhanced luminescence | Dec 22, 2019 | Issued |
Array
(
[id] => 16175546
[patent_doc_number] => 20200222514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => CARBAPENEMASES FOR USE WITH ANTIBIOTICS FOR THE PROTECTION OF THE INTESTINAL MICROBIOME
[patent_app_type] => utility
[patent_app_number] => 16/720999
[patent_app_country] => US
[patent_app_date] => 2019-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46599
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16720999
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/720999 | Carbapenemases for use with antibiotics for the protection of the intestinal microbiome | Dec 18, 2019 | Issued |
Array
(
[id] => 17029576
[patent_doc_number] => 11091380
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-17
[patent_title] => Composition and methods of use
[patent_app_type] => utility
[patent_app_number] => 16/707367
[patent_app_country] => US
[patent_app_date] => 2019-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 12
[patent_no_of_words] => 14083
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16707367
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/707367 | Composition and methods of use | Dec 8, 2019 | Issued |